Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

A new era of diabetes care Stem cell therapy represents a significant breakthrough in the treatment of type 1 diabetes. With the potential to offer insulin independence and long-term glycemic ...

The research team, studying the efficacy of a preventive antibody-based therapy, found it successfully protects monkeys from ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently ...

A breakthrough CAR-T cell therapy, Qartemi, has been approved for blood cancer patients in India, offering new hope to those ...

The US FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug, to treat chronic hepatitis delta ...

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.